<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Edwards Lifesciences Corp. (EW) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/ew/</link>
<description>Every dated entry in the public record on Edwards Lifesciences Corp.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/ew/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Wed, 23 Sep 2026 00:00:00 +0000</lastBuildDate>
<item><title>Edwards Lifesciences Corp.: Lippis Daniel J. (CVP, TAVR) sold 619 shares at $87.51 on 11 September 2026, $54,169</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-09-11:6752f99976</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826007774/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Form 144, Dahl Andrew M. plans to sell 544 shares worth $49,534 around 31 August 2026</title><link>https://greeksoup.ai/stocks/us/ew/planned-sales/</link><guid isPermaLink="false">us:EW:planned-sale:2026-08-31:db1a7d6884</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000192109426000970/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Dahl Andrew M. (SVP, Corporate Controller) sold 544 shares at $91.06 on 31 August 2026, $49,534</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-08-31:547fa55379</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826007408/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: short interest 9,022,064 shares at the 31 August 2026 settlement, 3.21 days to cover</title><link>https://greeksoup.ai/stocks/us/ew/short-interest/</link><guid isPermaLink="false">us:EW:short-interest:2026-08-31:e21bb2e7e8</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp. filed 8-K: officer or director change</title><link>https://greeksoup.ai/stocks/us/ew/filings/</link><guid isPermaLink="false">us:EW:filing:2026-08-28:118d1bdc41</guid><pubDate>Fri, 28 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000109980026000048/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Form 144, Bruls Annette plans to sell 2,644 shares worth $237,907 around 28 August 2026</title><link>https://greeksoup.ai/stocks/us/ew/planned-sales/</link><guid isPermaLink="false">us:EW:planned-sale:2026-08-28:35cb02ae20</guid><pubDate>Fri, 28 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000192109426000963/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Bruls Annette (CVP, EMEACLA) sold 2,644 shares at $89.98 on 28 August 2026, $237,907</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-08-28:75785561e8</guid><pubDate>Fri, 28 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826007377/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Form 144, Markowitz Wayne plans to sell 1,240 shares worth $113,417 around 26 August 2026</title><link>https://greeksoup.ai/stocks/us/ew/planned-sales/</link><guid isPermaLink="false">us:EW:planned-sale:2026-08-26:4cb4c7fcea</guid><pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000192109426000959/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Form 144, Chopra Daveen plans to sell 31,800 shares worth $2.9 million around 26 August 2026</title><link>https://greeksoup.ai/stocks/us/ew/planned-sales/</link><guid isPermaLink="false">us:EW:planned-sale:2026-08-26:7836709445</guid><pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000192109426000958/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Chopra Daveen (CVP, TMTT, Surgical &amp; IHFM) sold 1,154 shares at $91.76 on 26 August 2026, $105,893</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-08-26:f433d5cefa</guid><pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Chopra Daveen (CVP, TMTT, Surgical &amp; IHFM) sold 30,646 shares at $90.99 on 26 August 2026, $2.8 million</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-08-26:aa2c2a3f16</guid><pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Markowitz Wayne (CVP, JAPAC) sold 1,240 shares at $91.47 on 26 August 2026, $113,417</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-08-26:92ace0056c</guid><pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826007332/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: short interest 10,241,231 shares at the 14 August 2026 settlement, 3.14 days to cover</title><link>https://greeksoup.ai/stocks/us/ew/short-interest/</link><guid isPermaLink="false">us:EW:short-interest:2026-08-14:2fa746fbc7</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Form 144, Lippis Daniel J. plans to sell 1,857 shares worth $170,900 around 11 August 2026</title><link>https://greeksoup.ai/stocks/us/ew/planned-sales/</link><guid isPermaLink="false">us:EW:planned-sale:2026-08-11:f92399b445</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000192109426000827/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Lippis Daniel J. (CVP, TAVR) sold 619 shares at $92.03 on 11 August 2026, $56,967</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-08-11:048b05a993</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826007065/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp. Q2 FY2026 results: revenue $1.7 billion, net income $242 million</title><link>https://greeksoup.ai/stocks/us/ew/results/fy2026-q2/</link><guid isPermaLink="false">us:EW:result:2026-08-04:e9c053700a</guid><pubDate>Tue, 04 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001099800&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp. filed S-8: s-8</title><link>https://greeksoup.ai/stocks/us/ew/filings/</link><guid isPermaLink="false">us:EW:filing:2026-08-04:267d928153</guid><pubDate>Tue, 04 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000109980026000045/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/ew/filings/</link><guid isPermaLink="false">us:EW:filing:2026-08-04:0632fd780c</guid><pubDate>Tue, 04 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000109980026000043/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: short interest 10,043,721 shares at the 31 July 2026 settlement, 1.77 days to cover</title><link>https://greeksoup.ai/stocks/us/ew/short-interest/</link><guid isPermaLink="false">us:EW:short-interest:2026-07-31:ca0f7ed1d3</guid><pubDate>Fri, 31 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Form 144, Markowitz Wayne plans to sell 147 shares worth $12,588 around 30 July 2026</title><link>https://greeksoup.ai/stocks/us/ew/planned-sales/</link><guid isPermaLink="false">us:EW:planned-sale:2026-07-30:9c08816213</guid><pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000192109426000776/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Form 144, Ullem Scott B. plans to sell 50,000 shares worth $4.6 million around 30 July 2026</title><link>https://greeksoup.ai/stocks/us/ew/planned-sales/</link><guid isPermaLink="false">us:EW:planned-sale:2026-07-30:69eeb3e3fe</guid><pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000192109426000777/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Markowitz Wayne (CVP, JAPAC) sold 146 shares at $86.03 on 30 July 2026, $12,588</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-07-30:72a694835a</guid><pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826006853/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Form 144, Markowitz Wayne plans to sell 9,628 shares worth $818,958 around 28 July 2026</title><link>https://greeksoup.ai/stocks/us/ew/planned-sales/</link><guid isPermaLink="false">us:EW:planned-sale:2026-07-28:387469c97e</guid><pubDate>Tue, 28 Jul 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000192109426000762/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Markowitz Wayne (CVP, JAPAC) sold 9,628 shares at $85.06 on 28 July 2026, $818,958</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-07-28:52ed1b357e</guid><pubDate>Tue, 28 Jul 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826006777/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Form 144, Zovighian Bernard J plans to sell 2,921 shares worth $245,134 around 27 July 2026</title><link>https://greeksoup.ai/stocks/us/ew/planned-sales/</link><guid isPermaLink="false">us:EW:planned-sale:2026-07-27:e8fc00fa70</guid><pubDate>Mon, 27 Jul 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000192109426000758/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Zovighian Bernard J (CEO) sold 2,921 shares at $83.93 on 27 July 2026, $245,134</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-07-27:f790f64c80</guid><pubDate>Mon, 27 Jul 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826006743/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp. filed 8-K: results of operations</title><link>https://greeksoup.ai/stocks/us/ew/filings/</link><guid isPermaLink="false">us:EW:filing:2026-07-23:f05a4ed2c1</guid><pubDate>Thu, 23 Jul 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000109980026000038/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: short interest 11,352,019 shares at the 15 July 2026 settlement, 2.51 days to cover</title><link>https://greeksoup.ai/stocks/us/ew/short-interest/</link><guid isPermaLink="false">us:EW:short-interest:2026-07-15:bc2775ab15</guid><pubDate>Wed, 15 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Lippis Daniel J. (CVP, TAVR) sold 619 shares at $91.70 on 10 July 2026, $56,762</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-07-10:b46ce4fa67</guid><pubDate>Fri, 10 Jul 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826006576/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: Lippis Daniel J. (CVP, TAVR) sold 619 shares at $91.40 on 30 June 2026, $56,577</title><link>https://greeksoup.ai/stocks/us/ew/insiders/</link><guid isPermaLink="false">us:EW:insider:2026-06-30:67b202300f</guid><pubDate>Tue, 30 Jun 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1099800/000122520826006263/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Edwards Lifesciences Corp.: short interest 11,466,764 shares at the 30 June 2026 settlement, 2.11 days to cover</title><link>https://greeksoup.ai/stocks/us/ew/short-interest/</link><guid isPermaLink="false">us:EW:short-interest:2026-06-30:e05bbe1ba4</guid><pubDate>Tue, 30 Jun 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/ew/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
